Table 2.
Baseline characteristics of participants in the cross-sectional US-GoKinD, UK-ROI, and FinnDiane cohorts by DKD status
| US-GoKinD |
UK-ROI |
FinnDiane |
||||
|---|---|---|---|---|---|---|
| No DKD | DKD | No DKD | DKD | No DKD | DKD | |
| N | 807 | 761 | 831 | 674 | 1,262 | 912 |
| BMI (kg/m2) | 26.1 ± 8.6 | 25.7 ± 5.2 | 26.2 ± 4.1 | 26.3 ± 4.7 | 25.1 ± 3.33 | 25.3 ± 4.0 |
| Women (%) | 58.4 | 48.2 | 55.7 | 40.4 | 57.5 | 40.8 |
| Age (years) | 38.5 ± 8.6 | 43.2 ± 6.9 | 41.6 ± 11.0 | 48.4 ± 10.6 | 42.4 ± 11.6 | 43.1 ± 10.0 |
| Duration of diabetes (years) | 25.5 ± 7.7 | 31.3 ± 7.8 | 27.1 ± 8.6 | 33.5 ± 9.5 | 27.1 ± 9.0 | 30.0 ± 8.3 |
| HbA1c (%) | 7.5 ± 1.2 | 7.5 ± 1.9 | 8.6 ± 1.6 | 8.9 ± 1.8 | 8.2 ± 1.3 | 8.9 ± 1.6 |
| HbA1c (mmol/mol) | 58 ± 13.1 | 58 ± 20.8 | 70 ± 17.5 | 74 ± 19.7 | 66 ± 14.2 | 74 ± 17.5 |
| ESRD (%) | 0 | 65.4 | 0 | 33.1 | 0 | 35.0 |
Values are means ± SD except where indicated. N, number of participants.